Manulife (Manufacturers Life Insurance)’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,674
Closed -$312K 3044
2022
Q2
$312K Buy
+5,674
New +$298K ﹤0.01% 2368
2018
Q3
Sell
-60
Closed -$7K 4054
2018
Q2
$7K Hold
60
﹤0.01% 4018
2018
Q1
$5K Buy
+60
New +$6.8K ﹤0.01% 4120
2017
Q3
Sell
-18
Closed -$1K 4391
2017
Q2
$1K Sell
18
-2
-10% -$102 ﹤0.01% 4299
2017
Q1
$1K Hold
20
﹤0.01% 4122
2016
Q4
$1K Hold
20
﹤0.01% 4266
2016
Q3
$1K Hold
20
﹤0.01% 4213
2016
Q2
$2K Hold
20
﹤0.01% 4037
2016
Q1
$6K Buy
+20
New +$6.39K ﹤0.01% 3762

Other funds holding SRRA

Manulife (Manufacturers Life Insurance)'s SRRA Position: Q3 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 5,674 shares — an estimated $312K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SRRA in Q1 2016 and held it in 9 quarters. The position peaked at $312K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 5,674 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $312K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2016 and held it in 9 quarters.
  • Manulife (Manufacturers Life Insurance)'s Sierra Oncology, Inc. Common Stock position peaked at $312K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2022, filed 3 Nov 2022.